J. Stewart

Most-cited papers

1. Evaluation of a workplace health program to reduce coronary risk factors

   L. Makrides, G. Dagenais, A. Chockalingam, J. LeLorier +6 more

   200825 citations

   Semantic Scholar

   Save

2. Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: TRAVERSE Continuation Study.

   J. Máspero, Anju T. Peters, K. R. Chapman, Christian Domingo +11 more

   2023Journal of Allergy and Clinical Immunology: In Practice21 citations Open access

   Semantic Scholar

   Save

3. Alirocumab in high-risk patients: Observations from the open-label expanded use program.

   C. Glueck, Alan S. Brown, A. Goldberg, J. Mckenney +4 more

   2018Journal of Clinical Lipidology12 citations Open access

   Semantic Scholar

   Save

4. Impact of electrical cardioversion on quality of life for patients with symptomatic persistent atrial fibrillation: Is there a treatment expectation effect?

   A. Ha, J. Stewart, G. Klein, D. Roy +3 more

   2020American Heart Journal8 citations

   Semantic Scholar

   Save

5. PART 2 CAMERON ENERGY AN INDUSTRY CASE STUDY: MINIMIZING COST AND ENVIRONMENTAL IMPACT TO PLUG MORE WELLS

   J. Stewart

   2025Geological Society of America Abstracts with Programs0 citations

   Semantic Scholar

   Save

6. Long-term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: The Liberty Asthma Traverse Continuation Study

   J. Máspero, A. Peters, K. Chapman, C. Domingo +11 more

   2023World0 citations

   Semantic Scholar

   Save

7. ALIROCUMAB IN HIGH-RISK PATIENTS WITH BASELINE LDL-C ≥160 MG/DL: FINDINGS FROM THE COMPASSIONATE USE PROGRAM

   C. Glueck, Alan S. Brown, A. Goldberg, J. Mckenney +4 more

   20170 citations Open access

   Semantic Scholar

   Save

8. For ‘Patients of Moderate Means’: The Transformation of Ontario’s Public General Hospitals, 1880–1950

   D. Gagan, David Davies, D. Bercuson, B. Greenhous +24 more

   20160 citations

   Semantic Scholar

   Save